Spectaire (SPEC) Competitors $0.0011 0.00 (0.00%) As of 07/3/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsInsider TradesSEC FilingsTrendsBuy This Stock SPEC vs. THMO, HTGMQ, OLITW, PRENW, QSIAW, SMAPW, TT, KEYS, VLTO, and FTVShould you be buying Spectaire stock or one of its competitors? The main competitors of Spectaire include ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), Keysight Technologies (KEYS), Veralto (VLTO), and Fortive (FTV). These companies are all part of the "measuring and control equipment" industry. Spectaire vs. Its Competitors ThermoGenesis HTG Molecular Diagnostics OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition Trane Technologies Keysight Technologies Veralto Fortive ThermoGenesis (NASDAQ:THMO) and Spectaire (NASDAQ:SPEC) are both small-cap measuring and control equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, profitability, risk and institutional ownership. Which has more risk and volatility, THMO or SPEC? ThermoGenesis has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500. Comparatively, Spectaire has a beta of -6.37, indicating that its stock price is 737% less volatile than the S&P 500. Which has stronger earnings & valuation, THMO or SPEC? Spectaire has lower revenue, but higher earnings than ThermoGenesis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioThermoGenesis$9.61M0.00-$17.98M-$5.14N/ASpectaireN/AN/A$8.95MN/AN/A Does the media prefer THMO or SPEC? In the previous week, ThermoGenesis' average media sentiment score of 0.00 equaled Spectaire'saverage media sentiment score. Company Overall Sentiment ThermoGenesis Neutral Spectaire Neutral Do insiders & institutionals hold more shares of THMO or SPEC? 5.8% of ThermoGenesis shares are owned by institutional investors. Comparatively, 26.5% of Spectaire shares are owned by institutional investors. 78.0% of ThermoGenesis shares are owned by company insiders. Comparatively, 25.4% of Spectaire shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is THMO or SPEC more profitable? ThermoGenesis' return on equity of 0.00% beat Spectaire's return on equity.Company Net Margins Return on Equity Return on Assets ThermoGenesisN/A N/A N/A Spectaire N/A -81.22%304.57% SummaryThermoGenesis beats Spectaire on 4 of the 7 factors compared between the two stocks. Get Spectaire News Delivered to You Automatically Sign up to receive the latest news and ratings for SPEC and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SPEC vs. The Competition Export to ExcelMetricSpectaireMeasuring & controlling devices IndustryComputer SectorNASDAQ ExchangeMarket Cap$20K$36.22M$27.72B$9.03BDividend YieldN/A8.09%3.12%3.99%P/E RatioN/A4.2637.2420.25Price / SalesN/A3.482,028.42161.89Price / CashN/A8.3838.5158.10Price / Book0.001.827.225.67Net Income$8.95M$7.16M$763.57M$249.21M7 Day PerformanceN/A3.89%2.80%3.28%1 Month PerformanceN/A19.90%5.52%3.95%1 Year PerformanceN/A11.58%52,212.03%20.98% Spectaire Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SPECSpectaireN/A$0.00flatN/A-99.8%$20KN/A0.008THMOThermoGenesisN/AN/AN/AN/A$1K$9.61M0.0040HTGMQHTG Molecular DiagnosticsN/A$0.00flatN/AN/A$0.00$6.37M0.0090OLITWOmniLit AcquisitionN/A$0.09flatN/A-30.0%$0.00N/A0.003Gap UpPRENWPrenetics GlobalN/A$0.04-1.8%N/A+175.2%$0.00$41.52M0.001Positive NewsQSIAWQuantum-SiN/A$0.63-10.6%N/A+384.9%$0.00$3.44M0.00150Positive NewsGap UpSMAPWSportsMap Tech AcquisitionN/A$0.04flatN/AN/A$0.00N/A0.00N/AGap DownTTTrane Technologies4.3497 of 5 stars$430.92-0.7%$430.13-0.2%+32.5%$96.13B$19.84B35.8645,000News CoveragePositive NewsAnalyst ForecastKEYSKeysight Technologies4.38 of 5 stars$164.85+0.2%$183.00+11.0%+15.3%$28.38B$4.98B38.7115,500News CoveragePositive NewsInsider TradeVLTOVeralto2.9689 of 5 stars$102.95+0.3%$110.09+6.9%+8.5%$25.51B$5.19B29.4117,000News CoveragePositive NewsFTVFortive4.9292 of 5 stars$53.46+0.6%$77.08+44.2%-26.8%$18.17B$6.23B23.4518,000News CoverageAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies THMO Alternatives HTGMQ Alternatives OLITW Alternatives PRENW Alternatives QSIAW Alternatives SMAPW Alternatives TT Alternatives KEYS Alternatives VLTO Alternatives FTV Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SPEC) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spectaire Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spectaire With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
